Amendment No. 1 to Development Collaboration Agreement by and between Lixte Biotechnology Holdings, Inc and the Netherlands Cancer Institute, Amsterdam, and the Oncode Institute, Utrecht, entered into on October 8, 2021
Contract Categories:
Business Operations
- Collaboration Agreements
EX-10.3 2 ex10-3.htm
Exhibit 10.3
